112 results
Page 4 of 6
8-K
EX-99.1
6ti33pgtprw79sdibs6
1 Mar 21
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
9:01am
8-K
EX-1.1
g0mqm uswpqvmv
5 Feb 21
Other Events
5:27pm
424B5
sgi2jqogr rl
5 Feb 21
Prospectus supplement for primary offering
5:26pm
424B5
uc44ri ou
3 Feb 21
Prospectus supplement for primary offering
5:12pm
8-K
EX-2.1
q00jq61d06hqpks5o
5 Jan 21
Entry into a Material Definitive Agreement
4:49pm
8-K
im1qsv7ebas
16 Sep 20
Departure of Directors or Certain Officers
4:01pm
8-K
0pkxg976 9j2ih
21 Jul 20
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
kbjbf4fa4dvi
21 Jul 20
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
h03e72yfm fla7e
8 Jan 20
Rhythm Pharmaceuticals Announces Leadership Transition
4:00pm
8-K
EX-99.1
v1ptho89m
6 Nov 19
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
9:28am